Clinical Trials
Study Title:
GOG-3076 a Phase 3 Trial in Platinum-Resistant/Refractory Ovarian Cancer
For more information about the trial above please contact the study team:
Medical University of South Carolina Principal Investigator, Whitney Graybill, at graybill@musc.edu. Study Coordinator, Crystal Knox, at knoxc@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |